MYC and neoplasm: In particular, c-Myc inhibition using a dominant negative form of the protein termed OMOMYC was shown to regress tumours from both lung and pancreatic mouse tumour models.16, 17 Importantly, although expression of OMOMYC suppressed proliferation in various tissues, these effects were completely reversed upon cessation of treatment.